The Board of Directors of Sapporo Clinical Laboratory Inc. has authorized a buyback plan on May 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
995 JPY | +0.40% | -7.44% | -0.60% |
1st Jan change | Capi. | |
---|---|---|
-0.60% | 21.15M | |
-5.44% | 9.36B | |
+30.58% | 1.33B | |
-10.92% | 366M | |
+5.08% | 275M | |
+12.22% | 231M | |
-6.42% | 89.48M | |
+19.73% | 59.34M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.